Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Buy
5,498
+42
+0.8% +$14.4K 1.22% 15
2026
Q1
$1.92M Buy
5,456
+46
+0.9% +$16.4K 1.37% 9
2025
Q4
$1.77M Hold
5,410
1.34% 12
2025
Q3
$1.53M Buy
5,410
+28
+0.5% +$8.12K 1.18% 15
2025
Q2
$1.5M Buy
+5,382
New +$1.52M 1.25% 12

Other funds holding AMGN

Rexford Capital's AMGN Position: Q2 2026 in Review

Rexford Capital increased its Amgen (AMGN) stake by 0.77% in Q2 2026, buying an estimated $14.4K and bringing the position to 5,498 shares worth $1.99M. The position accounts for 1.22% of the portfolio, ranked #15.

Rexford Capital first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Rexford Capital held 5,498 shares of Amgen worth $1.99M as of Q2 2026.
  • Rexford Capital bought 42 Amgen shares in Q2 2026, an estimated $14.4K.
  • Amgen made up 1.22% of Rexford Capital's portfolio in Q2 2026, its #15 holding.
  • Rexford Capital first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.